Celgene Investor Says Info Scant On $74B Bristol-Myers Union
Celgene Corp. and Bristol-Myers Squibb Co. were hit with a proposed class action on Monday, as a Celgene investor claimed in Delaware federal court that not enough information has been provided...To view the full article, register now.
Already a subscriber? Click here to view full article